119 results
Page 4 of 6
8-K
6w67 yd6y8cgc36dox
27 Jul 20
Results of Operations and Financial Condition
4:02pm
8-K
EX-99.1
ufz99ixkwalh5aw0
12 May 20
BioXcel Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update
11:17am
8-K
2q5lcrq
14 Apr 20
Regulation FD Disclosure
8:18pm
8-K
EX-99.1
i6n70au0
14 Apr 20
Regulation FD Disclosure
8:18pm
8-K
EX-99.1
irezpenvz9fujeq63x
9 Mar 20
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
8:00am
424B5
7ttk20r8k6 xa
20 Feb 20
Prospectus supplement for primary offering
9:54pm
8-K
EX-1.1
xmnu4kb9dt ig
20 Feb 20
Entry into a Material Definitive Agreement
9:50pm
8-K
r9d1j fkb7wa
19 Feb 20
Results of Operations and Financial Condition
5:11pm
424B5
zmwuvsvp7 uyxr6
19 Feb 20
Prospectus supplement for primary offering
5:07pm
8-K
EX-99.1
1jxsvefdqjgrcxjr
14 Nov 19
BioXcel Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
8:00am
424B5
1xec6
28 Sep 19
Prospectus supplement for primary offering
1:42am
8-K
EX-1.1
axe6h6p6v
27 Sep 19
Other Events
5:31pm
424B5
h2rx3aqzzv3wi1o7uf8
25 Sep 19
Prospectus supplement for primary offering
4:58pm
8-K
EX-99.1
ion8v 65s0
6 Aug 19
BioXcel Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
8:06am
8-K
EX-99.1
t4p6l5t g5gv
22 Jul 19
Regulation FD Disclosure
9:29am
8-K
EX-99.2
slth8hvt48y
22 Jul 19
Regulation FD Disclosure
9:29am